Results 91 to 100 of about 3,851,574 (405)

Combination Therapy With Vigabatrin and Prednisolone Versus Vigabatrin Alone for Infantile Spasms

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The study evaluated the effectiveness of combination therapy with vigabatrin and prednisolone versus vigabatrin alone for treating infantile epileptic spasms syndrome (IESS). Methods This single‐center, single‐blind, randomized trial enrolled infants aged 2–14 months with new‐onset IESS, randomly assigned them (1:1) to receive either
Rachata Boonkrongsak, Kantapon Trongkamolchai, Sirorat Suwannachote, Somjit Sri‐Udomkajorn, Raviwan Wittawassamrankul, Ravindra Arya, Kullasate Sakpichaisakul   +6 more
wiley   +1 more source

Access to training in neurosurgery (Part 1): Global perspectives and contributing factors of barriers to access

Brain and Spine, 2022
Introduction: Neurological disorders are one of the leading causes of death and disability adjusted life years (DALYs). Efforts have been made to increase the neurosurgical workforce in an attempt to address the global disease burden.
Kwadwo Sarpong, Tarig Fadalla, Deen L. Garba, Mazin Suliman, Myron Rolle, Adam Ammar, Haytham Hussen, Kee B. Park   +7 more
doaj  

Estimating Budget Impact and Joint Replacement Avoidance by Implementing a Standardized Education and Exercise Therapy Program for Hip and Knee Osteoarthritis in a Publicly Insured Health Care System

Arthritis Care &Research, EarlyView.
Objective The study objective was to estimate the budget impact of funding a standardized education and exercise therapy program, Good Life with osteoArthritis in Denmark (GLA:D) for people with hip and knee osteoarthritis (OA) waiting for total joint replacement (TJR) consultation in a universal publicly insured health care system in Canada.
Darren R. Mazzei, Jackie L. Whittaker, Peter Faris, Tracy Wasylak, Deborah A. Marshall   +4 more
wiley   +1 more source

Cooperation and interdependence in global science funding [PDF]

arXiv, 2023
Investments in research and development are key to scientific and economic growth and to the well-being of society. Scientific research demands significant resources making national scientific investment a crucial driver of scientific production.
arxiv  

Mental Health Service Provision in Low- and Middle-Income Countries

Health Services Insights, 2017
This article discusses the provision of mental health services in low- and middle-income countries (LMICs) with a view to understanding the cultural dynamics–how the challenges they pose can be addressed and the opportunities harnessed in specific ...
S. Rathod, N. Pinninti, Muhammed Irfan, Paul Gorczynski, Pranay Rathod, L. Gega, Farooq Naeem   +6 more
semanticscholar   +1 more source

Managing COVID-19 in Low- and Middle-Income Countries.

Journal of the American Medical Association (JAMA), 2020
The public health response to coronavirus disease 2019 (COVID-19) in China has illustrated that it is possible to contain COVID-19 if governments focus on tried and tested public health outbreak responses.1,2 Isolation, quarantine, social distancing, and
J. Hopman, B. Allegranzi, S. Mehtar
semanticscholar   +1 more source

The future of psychiatry in low- and middle-income countries [PDF]

Psychological Medicine, 2009
The great shortage, and inequitable distribution, of psychiatrists in low- and middle-income countries is one of the key reasons for the large treatment gap for people with mental disorders. Psychiatrists need to play a public mental health leadership role in increasing the coverage of mental health care through task shifting of effective interventions
openaire   +4 more sources

Building neurosurgical capacity in low and middle income countries

eNeurologicalSci, 2016
Neurosurgery capacity in low- and middle-income countries is far from adequate; yet burden of neurological diseases, especially neuro-trauma, is projected to increase exponentially.
Anthony Fuller, Tu Tran, Michael Muhumuza, Michael M. Haglund   +3 more
doaj   +1 more source

Cardiovascular risk and events in 17 low-, middle-, and high-income countries [PDF]

, 2014
BACKGROUND: More than 80% of deaths from cardiovascular disease are estimated to occur in low-income and middle-income countries, but the reasons are unknown. METHODS: We enrolled 156,424 persons from 628 urban and rural communities in 17 countries
Anand, Sonia, Avezum, Alvaro, Bo, Jian, Chifamba, Jephat, Dagenais, Gilles, Diaz, Rafael, Gupta, Rajeev, Iqbal, Romaina, Islam, Shofiqul, Ismail, Noorhassim, Kelishadi, Roya, Kruger, Annamarie, Kumar, Rajesh, Lanas, Fernando, Lear, Scott, Li, Wei, Liu, Lisheng, Liu, Tianlu, Lopez-Jaramillo, Patricio, Lou, Qinglin, Lu, Fanghong, McKee, Martin, McQueen, Matthew, Mohan, Viswanathan, Mony, Prem, Oguz, Aytekin, Puoane, Thandi, PURE Investigators, Rahman, Omar, Rangarajan, Sumathy, Rosengren, Annika, Swaminathan, Sumathi, Szuba, Andrzej, Teo, Koon, Vijayakumar, Krishnapillai, Wielgosz, Andreas, Yu, Liu, Yusoff, Khalid, Yusuf, Salim, Yusufali, Afzalhussein, Zhang, Shiying   +40 more
core   +2 more sources

Measuring antibiotic availability and use in 20 low- and middle-income countries [PDF]

, 2020
Objective To assess antibiotic availability and use in health facilities in low- and middle-income countries, using the service provision assessment and service availability and readiness assessment surveys.
Hsia, Y, Knowles, R, Magrini, N, Moja, L, Sharland, M, Siyam, A, Tayler, E   +6 more
core   +2 more sources